鲁抗医药
(600789)
| 流通市值：73.15亿 | | | 总市值：85.08亿 |
| 流通股本：8.99亿 | | | 总股本：10.45亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,110,032,099.52 | 2,344,308,789.62 | 786,358,617.39 | 716,996,053 |
| 交易性金融资产 | - | 0 | 0 | 0 |
| 应收票据及应收账款 | 961,310,208.86 | 748,512,673.19 | 955,387,979.32 | 1,103,764,942.54 |
| 应收账款 | 961,310,208.86 | 748,512,673.19 | 955,387,979.32 | 1,103,764,942.54 |
| 应收款项融资 | 141,039,851.52 | 267,158,630.02 | 442,313,517.64 | 444,234,258.86 |
| 预付款项 | 67,327,224.31 | 28,400,170.76 | 63,181,322.18 | 37,416,314.2 |
| 其他应收款合计 | 254,492,207.02 | 264,823,268.87 | 265,429,271.26 | 325,893,734.32 |
| 存货 | 1,248,844,492.52 | 1,247,390,887.6 | 1,266,992,024.09 | 1,258,666,581.05 |
| 其他流动资产 | 43,489,591.75 | 50,260,448.18 | 34,784,197.7 | 29,662,263.42 |
| 流动资产合计 | 4,826,535,675.5 | 4,950,854,868.24 | 3,814,446,929.58 | 3,916,634,147.39 |
| 非流动资产: | | | | |
| 长期股权投资 | 63,666,978.66 | 64,876,001.93 | 66,985,599.84 | 68,021,555.28 |
| 其他权益工具投资 | 14,936,305.34 | 15,390,578.96 | 15,818,043.94 | 16,417,126.21 |
| 投资性房地产 | 52,298,260.4 | 53,101,595.49 | 45,291,528.9 | 45,876,364.42 |
| 固定资产 | 3,651,300,670.25 | 3,660,309,716.46 | 3,521,977,199.92 | 3,578,008,406.03 |
| 在建工程 | 195,064,411.61 | 239,745,251.07 | 285,773,023.24 | 242,311,975.29 |
| 无形资产 | 774,936,278.63 | 786,788,695.72 | 778,340,228.64 | 784,077,942.74 |
| 开发支出 | 131,544,253.97 | 123,617,574.04 | 167,167,181.92 | 149,719,682.34 |
| 长期待摊费用 | 1,598,160.31 | 1,759,742.98 | 953,666.74 | 1,051,811.41 |
| 递延所得税资产 | 40,652,513.31 | 40,517,925.5 | 22,718,937.5 | 22,712,590.24 |
| 其他非流动资产 | 130,571,478.09 | 97,089,118.92 | 96,894,822.21 | 62,531,387.87 |
| 非流动资产合计 | 5,056,569,310.57 | 5,083,196,201.07 | 5,001,920,232.85 | 4,970,728,841.83 |
| 资产总计 | 9,883,104,986.07 | 10,034,051,069.31 | 8,816,367,162.43 | 8,887,362,989.22 |
| 流动负债: | | | | |
| 短期借款 | 915,511,855.95 | 1,108,005,648.05 | 1,038,320,911.92 | 915,130,842.18 |
| 应付票据及应付账款 | 1,262,925,721.31 | 1,047,883,671.18 | 1,105,138,118.26 | 1,268,976,331.86 |
| 其中：应付票据 | 336,195,460.03 | 123,043,000 | 255,858,000 | 480,872,944.89 |
| 应付账款 | 926,730,261.28 | 924,840,671.18 | 849,280,118.26 | 788,103,386.97 |
| 预收款项 | 571,541.17 | 47,342.38 | - | - |
| 合同负债 | 83,183,698.8 | 82,810,567.54 | 71,765,164.08 | 61,075,946.2 |
| 应付职工薪酬 | 19,752,605.89 | 24,830,130.52 | 16,745,419.93 | 17,692,754.97 |
| 应交税费 | 54,374,296.03 | 49,298,084.03 | 24,040,215.96 | 28,010,632.38 |
| 其他应付款合计 | 208,747,640.78 | 205,305,183.64 | 204,721,333.01 | 222,696,298.46 |
| 应付股利 | 1,680,905.49 | 1,680,905.49 | 2,683,705.49 | 1,680,905.49 |
| 一年内到期的非流动负债 | 594,983,035.22 | 872,298,798.12 | 723,382,257.89 | 626,018,435.69 |
| 其他流动负债 | 7,787,535.1 | 7,759,566.32 | 6,556,019.82 | 6,110,523.61 |
| 流动负债合计 | 3,147,837,930.25 | 3,398,238,991.78 | 3,190,669,440.87 | 3,145,711,765.35 |
| 非流动负债: | | | | |
| 长期借款 | 1,137,850,000 | 1,089,140,000 | 1,241,790,000 | 1,363,960,000 |
| 长期应付款 | 2,000,000 | 2,000,000 | 123,857,705 | 123,857,705 |
| 递延收益 | 282,585,940.24 | 288,027,696.59 | 155,220,624.46 | 162,484,304.36 |
| 非流动负债合计 | 1,422,435,940.24 | 1,379,167,696.59 | 1,520,868,329.46 | 1,650,302,009.36 |
| 负债合计 | 4,570,273,870.49 | 4,777,406,688.37 | 4,711,537,770.33 | 4,796,013,774.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,045,189,778 | 1,045,189,778 | 898,669,632 | 898,669,632 |
| 资本公积 | 2,738,446,286.56 | 2,738,446,286.56 | 1,698,137,293.88 | 1,698,137,293.88 |
| 其他综合收益 | -25,063,694.66 | -24,609,421.04 | -24,181,956.06 | -23,582,873.79 |
| 专项储备 | 1,652,655.49 | 1,546,046.83 | 1,419,858.77 | 1,488,399.77 |
| 盈余公积 | 212,098,421.8 | 212,098,421.8 | 207,388,115.67 | 207,388,115.67 |
| 未分配利润 | 1,195,242,748.24 | 1,141,989,364.93 | 1,175,591,052.2 | 1,162,050,245.62 |
| 归属于母公司股东权益合计 | 5,167,566,195.43 | 5,114,660,477.08 | 3,957,023,996.46 | 3,944,150,813.15 |
| 少数股东权益 | 145,264,920.15 | 141,983,903.86 | 147,805,395.64 | 147,198,401.36 |
| 股东权益合计 | 5,312,831,115.58 | 5,256,644,380.94 | 4,104,829,392.1 | 4,091,349,214.51 |
| 负债和股东权益合计 | 9,883,104,986.07 | 10,034,051,069.31 | 8,816,367,162.43 | 8,887,362,989.22 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-31 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |